
zzso zzso is a new agent which zzso into zzso zzso studies have demonstrated activity equal to or greater than that of zzso in all tumor systems zzso In this phase I clinical trial, the schedule of drug administration consisted of a 24-hour continuous zzso infusion repeated at zzso zzso zzso patients received a total of 66 courses over a dose range of zzso zzso The zzso toxic effect was zzso with a zzso count zzso on Day 12 and resolution prior to Day zzso Other toxic effects were zzso mild zzso and blue zzso of zzso zzso tumor responses were seen in a patient with zzso of the breast and in another patient with clear cell zzso of the zzso An additional six patients with acute leukemia were treated at a dose of 12 zzso a decrease in peripheral blast count was observed in four of these six zzso The toxicity of zzso by 24-hour zzso infusion was similar to that previously reported for zzso zzso zzso We recommend phase II evaluation of zzso at a dose of 12 zzso by single zzso injection at zzso zzso Patients with acute leukemia should be evaluated at higher dose zzso 

